Chronic lead exposure may be associated with erectile dysfunction

Journal of Sexual Medicine

Volumn 4, Issue 5, 2007, Pages 1428-1436

  Anis, Tarek H ^a   Elkaraksy, Ahmed ^a   Mostafa, Taymour ^a   Gadalla, Amr ^a   Imam, Hager ^b   Hamdy, Lamya ^b   Abu el Alla, Omayma ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Research Ophthalmology Institute   (Egypt)

Author keywords

Antioxidants; Cavernous Tissue; Erectile Dysfunction; Lead Exposure; Reactive Oxygen Species

Indexed keywords

ANTIOXIDANT; LEAD; PARAFFIN; PHOSPHODIESTERASE V INHIBITOR; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EGYPT; ELECTRON MICROSCOPY; ERECTILE DYSFUNCTION; HUMAN; LEAD BLOOD LEVEL; LONG TERM EXPOSURE; MALE; MEDICAL DOCUMENTATION; PATHOPHYSIOLOGY; PENIS PROSTHESIS; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; TISSUE SECTION; UNIVERSITY HOSPITAL;

EID: 34548312381     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00587.x     Document Type: Article

References (29)

1. Jarup L. Hazards of heavy metal contamination. Br Med Bull 2003;68:167-82.
2. Hunter D, ed. The diseases of occupations. 6th edition. London: Hodder and Stoughton; 1978.
3. Quinn MJ, Sherlock JC. The correspondence between U.K. 'action levels' for lead in blood and in water. Food Addit Contam 1990;7:387-424.
4. Phillip AT, Lead Gerson B. Poisoning - Part I. Incidence, etiology, and toxicokinetics. Clin Lab Med 1994;14:423-44.
5. Markowitz M. Lead poisoning. Pediatr Rev 2000;21:327-35.
6. Papanikolaou NC, Hatzidaki EG, Belivanis S, Tzanakakis GN, Tsatsakis AM. Lead toxicity update. A brief review. Med Sci Monit 2005;11:RA329-36.
7. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med 2002;162:2443-9.
8. Sokas RK, Simmens S, Sophar K, Welch LS, Liziewski T. Lead levels in Maryland construction workers. Am J Ind Med 1997;31:188-94.
9. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for lead. (Draft for Public Comment). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 2005:43-59.
10. Staessen JA, Bulpitt CJ, Fagard R, Lauwerys RR, Roels H, Thijs L, Amery A. Hypertension caused by low-level lead exposure: Myth or fact? J Cardiovasc Risk 1994;1:87-97.
11. Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health 1995;50:31-7.
12. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA. An epidemiological re-appraisal of the association between blood pressure and blood lead: A meta-analysis. J Hum Hypertens 2002;16:123-31.
13. Vaziri ND, Ding Y, Ni Z. Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 1999;34:558-62.
14. Behari JR. Determination of lead in blood. Int J Environ Anal Chem 1981;10:149-54.
15. Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem 1966;16:359-64.
16. Feigl F, ed. Spots in inorganic analysis. 5th edition. Amsterdam: Elsevier; 1958.
17. Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med 1975;85:337-41.
18. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47:389-94.
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
20. Jagota SK, Dani HM. A new colorimetric technique for the estimation of vitamin C using folin phenol reagent. Anal Biochem 1982;127:178-82.
21. Silbergeld EK. Toward the twenty-first century: Lessons from lead and lessons yet to learn. Environ Health Perspect 1990;86:191-6.
22. Ghazi-Khansari M, Heidari I, Zarrindast MR. Effects of lead exposure on bromocriptine-induced penile erection in rats. Pharmacol Toxicol 1997;81:81-4.
23. Vaziri ND, Ding Y, Ni Z, Gonick HC. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy. Kidney Int 1997;52:1042-6.
24. Gonick HC, Ding Y, Bondy SC, Ni Z, Vaziri ND. Lead-induced hypertension: Interplay of nitric oxide and reactive oxygen species. Hypertension 1997;30:1487-92.
25. Agarwal A, Nandipati KC, Sharma RK, Zippe CD, Raina R. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl 2006;27:335-47.
26. Bivalacqua TJ, Usta MF, Kendirci M, Pradhan L, Alvarez X, Champion HC, Kadowitz PJ, Hellstrom WJ. Superoxide anion production in the rat penis impairs erectile function in diabetes: Influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2005;2:187-97.
27. Saenz de Tejada I, Angulo J, Cellek S, Gonzalez-Cadavid N, Heaton J, Pickard R, Simonsen U. Pathophysiology of erectile dysfunction. J Sex Med 2005;2:26-39.
28. Jeremy JY, Jones RA, Koupparis AJ, Hotston M, Persad R, Angelini GD, Shukla N. Reactive oxygen species and erectile dysfunction: Possible role of NADPH oxidase. Int J Impot Res 2007;19:265-80.
29. Courtois E, Marques M, Barrientos A, Casado S, Lopez-Farre A. Lead-induced downregulation of soluble guanylate cyclase in isolated rat aortic segments mediated by reactive oxygen species and cyclooxygenase-2. J Am Soc Nephrol 2003;14:1464-70.